Importance: Impaired growth is an important factor in patients with disorders of sex development (DSD).
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Pediatric Investigation. 2017;1: 13-19 14 affected by abnormal testosterone levels, and gonadal dysplasia is associated with DSD impacts on the individual's physical development from the prenatal period through to adulthood. 2, 3 In addition to abnormal sexual development, impaired growth is additional key concerns in patients with DSD. We previously found that children with DSD were on average shorter than the normal reference standard for their age. 4 Whether or not children with DSD should undergo surgical removal of dysplastic gonads during childhood is a contentious issue. Some studies have shown that early removal of gonads appeared to protect against gonadal malignancy, while other studies emphasized the importance of early gonadal function for bone growth in these children. [5] [6] [7] [8] [9] Han et al assessed the heights of patients with complete androgen insensitivity syndrome and found that individuals who underwent gonad removal after adolescence or during adulthood were taller than those whose gonads were removed in the prepubertal phase, 10 suggesting that the sex hormones had a positive effect on height gain during the prepubertal period.
Sex hormone deficiencies in prepubertal DSD children appear to be inextricably linked to growth. 46, XY DSD includes a variety of diseases, such as 5-a reductase deficiency, androgen insensitivity syndrome, congenital adrenal hyperplasia (CAH), and gonad dysplasia. These sex hormone abnormalities affect the growth of DSD children, and evaluating the growth patterns of DSD children against reference standards developed for normal children may thus not be valid. Excess testosterone will promote the growth of DSD children in childhood, but because their epiphyseal plates close earlier than those of healthy children, their final heights will be short.
In comparison, testosterone deficiency is a direct cause of short stature. The severity of the defect and testosterone levels may thus vary, even within diseases with the same etiology, and the classification of growth curves for each disease is not necessarily helpful; the growth curve depends on the testosterone levels, rather than the specific disease. We therefore excluded patients with CAH because of high testosterone level from the current study.
To the best of our knowledge, no previous studies have quantified the growth patterns of children with DSD. This study therefore aimed to profile the physical developmental patterns of 0-16-yearold Chinese children with 46, XY DSD and to provide a reliable ref-
erence against which to assess the growth of these patients. 
| SUBJECTS AND METHODS

| Study population
| Growth curves
We described the growth index in each age category using the internationally accepted k-median coefficient of variation method for generating standard curves to calculate the median, coefficient of variation, and coefficient of skewness after converting the data into a normal distribution using Box-Cox transformation. 12 These parameters of smooth curves and the required percentile were calculated using age as an independent variable. Growth curves (P3, P10, P25, P50, P75, P90, P97 percentile curves and À3SD, À2SD, À1SD, 0SD, +1SD, +2SD, +3SD standard deviation curves) for children in the 0-3-year and 3-16-year age groups were compared with the corresponding normal reference curves.
| Human chorionic gonadotrophin (HCG) test
Human chorionic gonadotrophin was administered at a dose of 1500 IU/d for 4 days by intramuscular injection. 13 Blood samples (2 mL) were collected on the morning of the fifth day and tested for serum testosterone levels by enzyme enhanced chemiluminescence assay (SIE-MENS IMMULITE 2000, Munich, Germany). A serum testosterone level ≥100 ng/dL was graded as a good response, while <100 ng/dL was graded as a poor response. Based on these results, the study subjects were categorized into "good response" and "poor response" groups, respectively. HtSDS for children in these groups were compared with normal reference scores. All HCG tests were performed at the first visit.
| Ethics statement
Written informed consent was obtained from the parents/guardians and children (≥8 years old) in all cases. The study was approved by the ethics committee at Beijing Children's Hospital.
| Data analysis
The growth curves were calculated using LMS-chartmaker Light, 14 and curves were drawn using GraphPad Prism 6 software. SPSS 17.0 software was used for statistical analyses. Data pertaining to quantitative variables were expressed as mean AE standard deviation (SD).
Intergroup differences were assessed using t tests. P < .05 was considered statistically significant. 
| Growth curves
Height percentile curves for the good and poor response groups and for normal boys are presented in Figure 1A . The height of the study subjects began to lag significantly behind that of normal children from the age of 11 years, with the height lag being more pronounced in the poor response group. A scatter plot for height of subjects in the 0-16-year age group after quadratic curve fitting is shown in Figure 1B . The height of study subjects ˃7 years lagged behind that of normal boys, while the height curve in the poor response group was flat. The standard height curves for 0-3-year-old (N = 319) and 3-16-year-old (N = 236) study subjects are shown in Figures 2 and 3 , respectively. The standard weight and BMI curves for 0-3-year-olds and 3-16-year-old subjects are shown in Figures S1-S4 , respectively. Heights, weights, and BMI of three cases aged exactly 3 years were included in both groups.
| HCG standard test
The HCG standard test was conducted in 427 subjects, with a good 
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The two groups were stratified by age and assessed against the normal reference standards for boys ( Table 2 ). The HtSDS in the poor response group was generally lower than the normal reference value (P = .017). In children aged ≥12 years, the HtSDS values were significantly lower than the normal reference values for boys of the same age in both the good and poor response groups (P = .025 and P = .003, respectively). The HtSDS values in both groups were lower than the average height for normal boys (HtSDS = 0) across multiple age groups since 6 months. The average HtSDS values in the poor response groups were lower than those in the good response groups, except for children aged 24, 30 months.
| DISCUSSION
In this study, we profiled the growth patterns of non-CAH children with 46, XY DSD and developed a specific standard growth curve to monitor the physical development of these children. A percentile growth curve represents a useful, convenient, and easy to interpret tool, while more rigorous evaluations can be carried out using a standard deviation growth curve, which allows for better discrimination. 11, 15, 16 Our results showed that the HtSDS of DSD was lower than the average height of normal boys in multiple age groups since early infancy, irrespective of the HCG response, although the average HtSDS in the poor response group was lower than that in the good response group in most age groups. The HCG stimulation test only relatively reflects testicular Leydig cell function.
Most DSDs involve bone-age delay, and we previously found that height retardation was consistent with bone age. 4, 17 Tosson et al studied 45,X/46,XY DSD children and demonstrated growth retardation during the infant and adolescent periods, which eventually led to short stature. 18 Bertelloni et al 5 pointed out that the hormonal abnormalities in DSD patients may lead to abnormal bone growth, irrespective of racial differences. In a preliminary study in children with hypospadias, height and bone age increased after treatment, despite the shorter baseline heights of DSD children. 19 In the present study, we observed a lag in height gain during infancy, with an insufficient growth spurt during adolescence, further substantiating the need for specific growth assessment of DSD children. These results suggest that even trace amounts of testosterones produced by normal boys in early childhood may play a key role in growth and development. Overall, the accumulated evidence suggests that children with DSD may benefit from hormone replacement therapy not only during puberty, but also during infancy. Optimal preoperative testosterone replacement therapy in 46, XY DSD infants is not only beneficial to the success of operation, but also for the subsequent physical development of these children. 20 We also speculated that were referred to this center from other institutions across the country, thus reducing the impact of this issue. Secondly, the data of this study were obtained from clinical practice, and the heterogeneous age distribution was inevitable but a limitation. Thirdly, if we can accumulate enough samples to data every given single disease, it
would be more precise for the growth assessment.
In summary, we charted the physical growth curves of children with non-CAH 46, XY DSD to provide objective data and standards against which to evaluate their growth and development to help guide assessment precisely. Furthermore, 46, XY DSD-specific growth curves will improve our understanding of the growth dynamics and minimize the scope of bias in the growth assessment of children with 46, XY DSD. 
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